Moataz Reda, PhD

Principal Scientist
PDX Pharmaceuticals, Inc, United States

Presentation(s):

• Catheter-directed organ-targeting immune augmentation using a nanoparticle-based therapeutic in a rat de novo HCC model.

  Wednesday, April 2, 2025
  8:00 AM – 8:07 AM CT